DXSE:XETRA:XETRA-Xtrackers - Stoxx Europe 600 Health Care Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 241.75

Change

+1.00 (+0.42)%

Market Cap

USD 0.14B

Volume

840.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

ETFs Containing DXSE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.44% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.44% 88% B+ 85% B
Trailing 12 Months  
Capital Gain 19.80% 76% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.80% 76% C+ 75% C
Trailing 5 Years  
Capital Gain 71.26% 82% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 71.26% 82% B 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 8.55% 69% C- 67% D+
Dividend Return 8.55% 68% D+ 65% D
Total Return N/A 14% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 8.30% 65% D 72% C
Risk Adjusted Return 103.08% 99% N/A 98% N/A
Market Capitalization 0.14B 41% F 37% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.